Whole-body vibration plus vitamin D for adolescent girls with familial Mediterranean fever

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Forty adolescent girls with familial Mediterranean fever will be assigned to either a vibration group or a control group, with 20 participants in each arm. All participants will continue their regular colchicine and receive vitamin D daily for six months. The vibration group will also attend three 20-minute whole-body vibration sessions per week for six months. Outcomes measured will include functional performance, cardiorespiratory fitness, muscle strength, and bone mass, with assessments performed at baseline and after six months.

Why it matters

Who can join: the full rules

Inclusion Criteria:

FMF adolecent girls ages 13 -17 years forty patients

Exclusion Criteria:

cardiac problems renal problems liver problems diabetes brain problems

Where it's running

• Cairo University
  Giza, Dokki, Egypt Recruiting

Study contacts

• Principal investigator: Ali MA Ismail, lecturer — Cairo University
• Study coordinator: Ali MA Ismail, lecturer
• Email: ali.mohamed@pt.cu.edu.eg
• Phone: 01005154209

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Canakinumab use in FMF and Still's disease patients across real-world care

  This real-world study looks at how people with FMF or Still's disease who were treated with canakinumab fare over at least 6 months.

  Recruiting Novartis · Basel · NCT07517250

• Mediterranean diet with or without aerobic exercise for women with familial Mediterranean fever and fatty liver

  This trial will test whether adding regular aerobic exercise to a Mediterranean diet helps women with familial Mediterranean fever who have non-alcoholic fatty liver disease.

  Recruiting Cairo University · Dokki, Giza Governorate · NCT07130318

• Inspiratory muscle training for adolescents with Familial Mediterranean Fever

  This trial will try a daily inspiratory muscle training program to see if it improves breathing strength, exercise tolerance, and fatigue in teenagers (ages 13–17) with Familial Mediterranean Fever who are taking colchicine.

  Recruiting Cairo University · Giza, Dokki · NCT07129538

• Investigating the Role of Foods in Familial Mediterranean Fever Attacks

  This study is trying to see if certain foods, like gluten and wheat, can trigger or worsen attacks in people with Familial Mediterranean Fever.

  Recruiting University of Palermo · Palermo, Sicily · NCT06338891

• Using RPH-104 to prevent fever attacks in patients with Familial Mediterranean Fever who can't tolerate colchicine

  This study is testing if RPH-104 can help adults with Familial Mediterranean Fever who can’t take colchicine by preventing their fever attacks over a long period.

  Recruiting at 8 sites Phase 2 R-Pharm · Yerevan and 7 other locations · NCT05190991

• Testing a new diagnostic tool for Familial Mediterranean Fever

  This study is testing a new blood test to see if it can help doctors diagnose Familial Mediterranean Fever in people with certain gene mutations.

  Recruiting at 3 sites Hospices Civils de Lyon · Bron and 7 other locations · NCT04478409

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.